June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Allele-selective reduction of P23H-mutant rhodopsin with stereopure oligonucleotides rescues phenotype associated with retinitis pigmentosa in preclinical models
Author Affiliations & Notes
  • Michael Byrne
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • Vinod Vathipadickal
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • Lankai Guo
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • Yuan Yin
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • Hailin Yang
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • Richard Looby
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • Lauren Norwood
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • James W Fransen
    University of Louisville, Louisville, Kentucky, United States
  • archana jalligampala
    University of Louisville, Louisville, Kentucky, United States
  • Jennifer Noel
    University of Louisville, Louisville, Kentucky, United States
  • Chandra Vargeese
    Biology, Wave Life Sciences, Cambridge, Massachusetts, United States
  • Maureen A McCall
    University of Louisville, Louisville, Kentucky, United States
  • Footnotes
    Commercial Relationships   Michael Byrne, Wave Life Sciences (E); Vinod Vathipadickal, Wave Life Sciences (E); Lankai Guo, Wave Life Sciences (E); Yuan Yin, Wave Life Sciences (E); Hailin Yang, Wave Life Sciences (E); Richard Looby, Wave Life Sciences (E); Lauren Norwood, Wave Life Sciences (E); James Fransen, None; archana jalligampala, None; Jennifer Noel, None; Chandra Vargeese, Wave Life Sciences (E); Maureen McCall, Wave Life Sciences (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 185. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael Byrne, Vinod Vathipadickal, Lankai Guo, Yuan Yin, Hailin Yang, Richard Looby, Lauren Norwood, James W Fransen, archana jalligampala, Jennifer Noel, Chandra Vargeese, Maureen A McCall; Allele-selective reduction of P23H-mutant rhodopsin with stereopure oligonucleotides rescues phenotype associated with retinitis pigmentosa in preclinical models. Invest. Ophthalmol. Vis. Sci. 2021;62(8):185.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We tested whether a stereopure antisense oligonucleotide that selectively targets the P23H mutation in Rhodopsin (RHO) but that spares expression of healthy RHO transcripts can address phenotypes associated with the autosomal dominant form of retinitis pigmentosa (adRP) that is caused by this mutation.

Methods : We applied PRISMTM, Wave’s proprietary discovery and drug development platform, to generate stereopure antisense oligonucleotides that selectively target the RHO P23H mutation. We evaluated allele-selective activity of the oligonucleotides against RHO alleles with a luciferase reporter assay in Cos7 cells and in human retinal pigment epithelial (ARPE-19) cells that overexpress RHO. To assess target engagement and efficacy of the oligonucleotides in vivo, we evaluatedtheir activity in mouse and pig models for RHO P23H-induced adRP. Animals received intravitreal (IVT) injections, and eyes were evaluated for RHO P23H expression and expression of rod and cone cell markers by immunohistochemistry.

Results : We demonstrate that stereopure oligonucleotides selectively deplete expression of RHO P23H transcripts in vitro. After a single IVT eye injection of a stereopure oligonucleotide, expression of RHO P23H transcripts are decreased by at least 50% in mouse and pig models for RHO P23H-induced adRP. In the pig model, a single IVT injection led to the retention of rod outer segments and cone pedicles compared with untreated eyes 16-weeks post-injection.

Conclusions : These results confirm that stereopure oligonucleotides can selectively deplete expression of RHO P23H transcripts. These oligonucleotides deplete RHOP23H transcripts in vivo in multiple models and rescue phenotypes associated with adRP. Together, these data suggest stereopure oligonucleotides may provide a viable therapeutic opportunity for addressing RHO P23H-dependent adRP.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×